Rexam Expands in Plastic Packaging with £83m US Acquisition

Rexam has announced that it has agreed to acquire US-based Delta Plastics Inc for a total cash consideration of $154m (£83m), including repayments of borrowings and redemption of preference shares. The majority shareholder is Stonebridge Partners, a private equity fund.

The acquisition, which is subject to US competition authority approval, is expected to be earnings enhancing from the outset and to cover Rexam's cost of capital in 2007.

Delta Plastics is based in Hot Springs, Arkansas. It designs and manufactures plastic injection-moulded jars and closures for a variety of applications, primarily for the personal care and food markets. The company holds a number of patented product designs.

The operation, which employs more than 350 people, comprises two modern injection-moulding facilities in Hot Springs. It also has a technology centre, located near Los Angeles, California, which designs, develops and manufactures Delta Plastics' own moulds and automation equipment.

A combination of technology leadership, quality products and excellent customer service has enabled Delta Plastics to grow at a rate well above the market during the past five years. In 2004 it reported sales of $50m and, as at 31 December, net operating assets of $49m.

Commenting on the acquisition, Lars Emilson, Rexam's Chief Executive, said: "Delta Plastics is a well run operation that has posted impressive growth rates in recent years. The acquisition is perfectly in line with our strategy to grow our Plastic Packaging business and enhance our current product offering. It will increase our presence in the important US market and we foresee a number of synergies in areas such as raw materials purchasing, technology access and additional sales."

http://www.rexam.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.